Micron's $100 Billion Backlog: Are Take-or-Pay Agreements Changing the Memory Cycle?

Micron's $100 Billion Backlog: Are Take-or-Pa...

Up next

IBM NanoStack CFET: Turning Patents Into Chip Royalties

IBM just unveiled NanoStack, its take on the CFET transistor architecture that succeeds gate-all-around as the next step in chip scaling — and it could turn IBM's patent portfolio into a real semiconductor royalty business.IBM claims NanoStack delivers up to a 50% jump in compute ...  Show more

Jensen Called Marvell a $1T Stock — We're Not Buying It

Marvell (NASDAQ: MRVL) stock has surged since Jensen Huang called it the next trillion-dollar company — we ran a reverse DCF on the Q1 FY2027 earnings to see if the rally is justified.Marvell just posted record Q1 fiscal 2027 results, with revenue up 28% year-over-year to $2.4 bi ...  Show more

Recommended Episodes

DD131~6 High-Quality, Undervalued Semiconductor Stocks
Dapper Dividends

In this episode we discuss 6 High-Quality, Undervalued Semiconductor Stocks (LINK HERE), A Starbucks Covered call I sold, and trivia from Visual Capitali ...

  Show more

Nvidia Secures Massive AI Chip Deal with Saudi Arabia, Chime Files for IPO
The Rundown

Stock market update for May 14, 2025. Check out Generated Assets , Public's AI tool to help create custom investment ideas. The content of the video is for general and informational purposes only. All views presented in this show reflect the opinions of the guest and the host. Yo ...  Show more

Looking for Growth? This Tiny AI Stock Has MAJOR Potential
MarketBeat | Stock Market News & Analysis

Investors are always looking for the next stock before the big runup — and this tiny AI company might fit the bill. With analysts projecting up to 300% upside, the company's pivot from data storage to AI innovation could mark a major turning point. MarketBeat's Thomas Hughes brea ...  Show more

Beyond Nvidia: How to spot the next AI breakout for your portfolio
Stocks in Translation

Nvidia (NVDA) is stealing the AI spotlight, but the sector’s bench runs so much deeper. In this episode of Stocks in Translation, Epistrophy Capital Research Chief Market Strategist Cory Johnson joins host Jared Blikre and Senior Reporter Allie Canal to discuss the latest in AI. ...  Show more